logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 2
  • 1
    Caulfield, David John Moore
    Born in September 1979
    Individual (4 offsprings)
    Officer
    2019-09-12 ~ now
    OF - Director → CIF 0
    Mr David John Moore Caulfield
    Born in September 1979
    Individual (4 offsprings)
    Person with significant control
    2023-03-13 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Caulfield, Lindsay
    Born in October 1979
    Individual (1 offspring)
    Officer
    2020-01-20 ~ now
    OF - Director → CIF 0
    Lindsay Caulfield
    Born in October 1979
    Individual (1 offspring)
    Person with significant control
    2019-09-12 ~ now
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

CAULFIELD PHARMA CONSULTING LTD

Period: 2019-09-12 ~ now
Company number: 12203931
Registered name
CAULFIELD PHARMA CONSULTING LTD - now
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Intangible Assets
180 GBP2024-09-30
360 GBP2023-09-30
Property, Plant & Equipment
22,572 GBP2024-09-30
1,572 GBP2023-09-30
Fixed Assets
22,752 GBP2024-09-30
1,932 GBP2023-09-30
Debtors
26,451 GBP2024-09-30
12,032 GBP2023-09-30
Cash at bank and in hand
102,781 GBP2024-09-30
78,572 GBP2023-09-30
Current Assets
129,232 GBP2024-09-30
90,604 GBP2023-09-30
Creditors
Current
52,741 GBP2024-09-30
33,854 GBP2023-09-30
Net Current Assets/Liabilities
76,491 GBP2024-09-30
56,750 GBP2023-09-30
Total Assets Less Current Liabilities
99,243 GBP2024-09-30
58,682 GBP2023-09-30
Net Assets/Liabilities
98,170 GBP2024-09-30
58,383 GBP2023-09-30
Equity
Called up share capital
100 GBP2024-09-30
100 GBP2023-09-30
Retained earnings (accumulated losses)
98,070 GBP2024-09-30
58,283 GBP2023-09-30
Equity
98,170 GBP2024-09-30
58,383 GBP2023-09-30
Average Number of Employees
22023-10-01 ~ 2024-09-30
22022-10-01 ~ 2023-09-30
Intangible Assets - Gross Cost
Net goodwill
900 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
720 GBP2024-09-30
540 GBP2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
180 GBP2023-10-01 ~ 2024-09-30
Intangible Assets
Net goodwill
180 GBP2024-09-30
360 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
Computers
4,105 GBP2024-09-30
3,017 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
26,260 GBP2024-09-30
3,017 GBP2023-09-30
Furniture and fittings
656 GBP2024-09-30
Motor vehicles
21,499 GBP2024-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
1,882 GBP2024-09-30
1,445 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
3,688 GBP2024-09-30
1,445 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
14 GBP2023-10-01 ~ 2024-09-30
Motor vehicles
1,792 GBP2023-10-01 ~ 2024-09-30
Computers
437 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,243 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
14 GBP2024-09-30
Motor vehicles
1,792 GBP2024-09-30
Property, Plant & Equipment
Furniture and fittings
642 GBP2024-09-30
Motor vehicles
19,707 GBP2024-09-30
Computers
2,223 GBP2024-09-30
1,572 GBP2023-09-30
Trade Debtors/Trade Receivables
Current
26,263 GBP2024-09-30
11,233 GBP2023-09-30
Prepayments
Current
188 GBP2024-09-30
799 GBP2023-09-30
Debtors
Amounts falling due within one year, Current
26,451 GBP2024-09-30
12,032 GBP2023-09-30
Trade Creditors/Trade Payables
Current
533 GBP2024-09-30
224 GBP2023-09-30
Corporation Tax Payable
Current
15,690 GBP2024-09-30
1,562 GBP2023-09-30
Other Taxation & Social Security Payable
Current
1,292 GBP2024-09-30
1,291 GBP2023-09-30
Accrued Liabilities
Current
1,050 GBP2024-09-30
975 GBP2023-09-30
  • CAULFIELD PHARMA CONSULTING LTD
    Info
    Registered number 12203931
    1 Butterburn Close, Newcastle Upon Tyne, Tyne And Wear NE7 7GR
    PRIVATE LIMITED COMPANY incorporated on 2019-09-12 (6 years 10 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-07
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.